Plants as factories for production of biopharmaceutical and bioindustrial proteins: lessons from cell biologyThis review is one of a selection of papers published in the Special Issue on Plant Cell Biology.

2006 ◽  
Vol 84 (4) ◽  
pp. 679-694 ◽  
Author(s):  
Allison R. Kermode

Transgenic plants, seeds, and cultured plant cells are potentially one of the most economical systems for large-scale production of recombinant proteins for industrial and pharmaceutical uses. Biochemical, technical, and economic concerns with current production systems have generated enormous interest in developing plants as alternative production systems. However, various challenges must be met before plant systems can fully emerge as suitable, viable alternatives to current animal-based systems for large-scale production of biopharmaceuticals and other products. Aside from regulatory issues and developing efficient methods for downstream processing of recombinant proteins, there are at least two areas of challenge: (1) Can we engineer plant cells to accumulate recombinant proteins to sufficient levels? (2) Can we engineer plant cells to post-translationally modify recombinant proteins so that they are structurally and functionally similar to the native proteins? Attempts to improve the accumulation of a recombinant protein in plant cells require an appreciation of the processes of gene transcription, mRNA stability, processing, and export, and translation initiation and efficiency. Likewise, many post-translational factors must be considered, including protein stability, protein function and activity, and protein targeting. Moreover, we need to understand how the various processes leading from the gene to the functional protein are interdependent and functionally linked. Manipulation of the post-translational processing machinery of plant cells, especially that for N-linked glycosylation and glycan processing, is a challenging and exciting area. The functions of N-glycan heterogeneity and microheterogeneity, especially with respect to protein function, stability, and transport, are poorly understood and this represents an important area of cell biology.

2012 ◽  
Vol 18 (S5) ◽  
pp. 11-12 ◽  
Author(s):  
R.B. Santos ◽  
A.S. Pires ◽  
H.S. Silva ◽  
and R. Abranches

The use of transgenic plants for the large scale production of recombinant proteins with commercial and therapeutic value has emerged as an alternative to conventional platforms. Plant based systems, including whole plants and plant cell cultures offer many advantages particularly regarding safety and cost effectiveness. In our laboratory we have been using the model plant Medicago truncatula as a system to express recombinant proteins with a variety of applications.


2005 ◽  
pp. 225-237 ◽  
Author(s):  
Heidi Sisniega ◽  
José-Luis Río ◽  
María-José Amaya ◽  
Ignacio Faus

1988 ◽  
Vol 16 (4) ◽  
pp. 323-335
Author(s):  
Urs Karrer

A research project was started in 1985 to explore large-scale production systems which have a strong impact on the development of quality courseware. The exploration and evaluation of these production systems contribute to the explanation of the overall unsatisfactory quality of courseware. This article focuses on results of a survey which was conducted in January 1987 addressing more than sixty profit and nonprofit institutions in England, the federal Republic of Germany, the Netherlands, Switzerland, and the United States. The survey revealed interesting results in various fields. The five working hypotheses (production strategy, production approach, and quality factors for courseware development) were confirmed to a great extent. These results may be instructional for institutions which recently joined this area and/or are planning to do so.


Sign in / Sign up

Export Citation Format

Share Document